Fidelity Advisor Health Care Fund
Fidelity Advisor Series VII · 5 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Fidelity Advisor Health Care Fund is an actively managed U.S. equity fund.
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2025 Q3
Fidelity Advisor Health Care Fund seeks capital appreciation.
The fund invests primarily in common stocks of companies principally engaged in health care and medicine, including biotechnology, pharmaceuticals, medical devices and equipment, and health care facilities and managed plans, using fundamental analysis of financial condition, industry position, and market conditions to select holdings. The fund normally maintains at least 80% of assets in health care securities and may invest in both domestic and foreign issuers. As of December 11, 2025, the fund's 80% policy includes derivative instruments providing exposure to health care investments or related market risk factors.
| Share class | Expense ratio |
|---|---|
| FACDX | 0.93% |
| FHCCX | 1.68% |
| FACTX | 1.18% |
| FHCIX | 0.68% |
| FIKCX | 0.56% |
Portfolio turnover 52.00% · as of 2025 Q3
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.72% |
| Cash & short-term | 1.51% |
| Bonds | 0.18% |
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Health Care | 84.9% |
| International | 11.3% |
| Other | 2.3% |
| Cash | 1.5% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +11.19% | -69.27% | -93.03% | 14.34% | -73.46% | |
| +10.36% | -10.90% | -34.84% | 14.33% | -22.49% | |
| +10.91% | -48.77% | -79.61% | 14.33% | -55.63% | |
| +11.46% | +13.91% | +7.65% | 14.34% | -13.59% | |
| +11.61% | +14.30% | +8.34% | 14.35% | -13.54% |
These classes hold the same portfolio, so the 101.37pp spread over 5 years is the cost difference between them — roughly 20.27pp a year — not a difference in what they own.
Debt profile
What this fund holds — value-weighted across its bond and securitized long positions · as of 2026-04-30
Share of the fund's debt by how its coupon behaves — the fact that decides whether a rate move reaches this portfolio at all.
| Fixed rate | 71.2% |
| Floating rate | 28.8% |
Share of the fund's debt value in each maturity band, shortest first.
| <1y | 71.2% |
| 10y+ | 28.8% |
Based on what filers reported; a filer that never reported a flag also reads as none.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| LLY | ELI LILLY and COLLY | 6.93% | $934.60 | $200.00M | 214.0K |
| DHR | DANAHER CORPDHR | 6.79% | $178.95 | $195.95M | 1.1M |
| JNJ | JOHNSON and JOHNSONJNJ | 5.67% | $229.85 | $163.65M | 712.0K |
| TMO | THERMO FISHER SCIENTIFIC INCTMO | 3.62% | $478.96 | $104.41M | 218.0K |
| UNH | UNITEDHEALTH GROUP INCUNH | 3.02% | $370.48 | $87.06M | 235.0K |
| BSX | BOSTON SCIENTIFIC CORPBSX | 2.79% | $57.61 | $80.65M | 1.4M |
| — | ASCENDIS PHARMA A/S | 2.70% | $229.38 | $77.99M | 340.0K |
| ALNY | ALNYLAM PHARMACEUTICALS INCALNY | 2.44% | $309.49 | $70.56M | 228.0K |
| GILD | GILEAD SCIENCES INCGILD | 2.27% | $130.84 | $65.42M | 500.0K |
| ABBV | ABBVIE INCABBV | 2.23% | $211.32 | $64.24M | 304.0K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-04-30 — not a live quote, and not what the fund paid.
Top 10 positions are 38.45% of net assets, top 25 59.42%, across 124 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free